US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ドイツ
TG
Newron Pharmaceuticals Spa. (NP5) 銘柄情報

Newron Pharmaceuticals Spa. (NP5)

12.85

-0.40

( -3.02% )

更新日時： 01:16:36

Newron Pharmaceuticals Spa. (NP5) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

12.85

( -3.02% )

買値

12.75

売値

12.85

出来高

1,023

12.85 日の範囲 13.20

7.05 52 週間の範囲 34.15

時価総額

前日終値

13.25

始値

13.20

時刻

最終取引時間

00:43:25

財務取引量

-

VWAP

-

平均取引量 (3 か月)

81,847 €

発行済株式数

20,014,585

配当利回り

PER

-20.05

1 株当たり利益 (EPS)

-0.66

歳入

19.13M

純利益

-13.24M

Newron Pharmaceuticals S.p.A., a biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson’s in the European... Newron Pharmaceuticals S.p.A., a biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson’s in the European Union, the United Kingdom, the United States, Latin America, Switzerland, and Japan. The company’s lead compound includes Evenamide, an add-on therapy for the treatment of Schizophrenia and treatment-resistant schizophrenia, which is in Phase III clinical trial; and Ralfinamide for the treatment of rare neuropathic pain indication. It has a strategic partnership with Zambon and Meiji Seika Pharma Co., Ltd. for the commercialization of safinamide. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.newron.com

本社

Bresso, Italy

設立

1999

Newron Pharmaceuticals Spa. is listed in the Healthcare sector of the Tradegate (DE) with ticker NP5. The last closing price for Newron Pharmaceuticals was 13.25 €. Over the last year, Newron Pharmaceuticals shares have traded in a share price range of 7.05 € to 34.15 €.

Newron Pharmaceuticals currently has 20,014,585 shares in issue. The market capitalisation of Newron Pharmaceuticals is 257.19 € million. Newron Pharmaceuticals has a price to earnings ratio (PE ratio) of -20.05.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-1.2	-8.5409252669	14.05	14.2	12.8	7045	13.36593283	DE
4	-2.7	-17.3633440514	15.55	16.75	12.8	4801	14.55672103	DE
12	-4.57	-26.2342135476	17.42	19	12.75	5202	15.72058842	DE
26	-7.75	-37.6213592233	20.6	34.15	12.75	6861	21.34744266	DE
52	4.35	51.1764705882	8.5	34.15	7.05	6053	17.46378837	DE
156	8.43	190.7239819	4.42	34.15	4.2	7352	10.87327238	DE
260	10.5	446.808510638	2.35	34.15	1.13	5645	9.66952099	DE

NP5 - Frequently Asked Questions (FAQ)

What is the current Newron Pharmaceuticals Spa. share price?

The current share price of Newron Pharmaceuticals Spa. is 12.85 €

How many Newron Pharmaceuticals Spa. shares are in issue?

Newron Pharmaceuticals Spa. has 20,014,585 shares in issue

What is the market cap of Newron Pharmaceuticals Spa.?

The market capitalisation of Newron Pharmaceuticals Spa. is EUR 257.19M

What is the 1 year trading range for Newron Pharmaceuticals Spa. share price?

Newron Pharmaceuticals Spa. has traded in the range of 7.05 € to 34.15 € during the past year

What is the PE ratio of Newron Pharmaceuticals Spa.?

The price to earnings ratio of Newron Pharmaceuticals Spa. is -20.05

What is the cash to sales ratio of Newron Pharmaceuticals Spa.?

The cash to sales ratio of Newron Pharmaceuticals Spa. is 14.46

What is the registered address of Newron Pharmaceuticals Spa.?

The registered address for Newron Pharmaceuticals Spa. is Via Antonio Meucci 3, Bresso, Milan, 20091

What is the Newron Pharmaceuticals Spa. website address?

The website address for Newron Pharmaceuticals Spa. is www.newron.com

Which industry sector does Newron Pharmaceuticals Spa. operate in?

Newron Pharmaceuticals Spa. operates in the Biotechnology & Life Sciences sector

US Market News

US Market News 1分前

Strategy and Diageo Show How a Universal Context Layer Can Simplify Data Complexity and Accelerate AI Readiness at Gartner Data & Analytics Summit London 2026June 9, 2026 12:09 PM
Business Wire Strategy and Diageo highlighted how a universal context layer can help enterprises r

nowwhat2

nowwhat2 1分前

Eviscerating the clueless......Just slashing their guts out.

https://investorshub.advfn.com/uimage/uploads/2026/6/9/lvhlcBTC_JUNE_9_10Y_730am_THRU_200_SNIP_TEMP.jpg

YESTERDAY
https://investorshub.advfn.com/uimage/uploads/2026/6/9/qanxsETH_

sloppyjones

sloppyjones 2分前

I am preferring the jump after the cat is out of the bag. Most of us are loaded with shares about to retire.

This spring is wound up so tight, there is no telling what will happen. We've all experienced what would've happened if this was trading. I for one am ready to see what h

kid70

Monday prs looks like it was more negative than positive. Has anyone have opinion on the sec filings and the investment in smkt

Lone Clone

Lone Clone 2分前

Cambria Gold Reports First Results from Premier Underground Infill Drilling: Including 19.82 g/t Au over 5.0 meters and 483.0 g/t Au over 1.0 meters at Prew Zone

https://www.newsfilecorp.com/release/300658/Cambria-Gold-Reports-First-Results-from-Premier-Underground-Infill-Drilling-Inc

jhdf51

Thanks. Great point.

JHD

Monksdream

Monksdream 2分前

MTEN over $9 not even 12,30 yet

Monroe1

Monroe1 3分前

Doesn't look like lately any small volume. Really strong volume today maybe from the Apple presentation yesterday. I think the silence from the company for so very long has not served them well. However, they know better than any of us the path forward unraveling. Anything really negative would have

BBANBOB

BBANBOB 3分前

FRED

I TOO could get real used to and an appreciate it a lot better if IF IFIN I was actually seeing it in my acct.
NO offense you may be SPOT ON THAT WE ARE receiving those but for all we know we aren't

creakyhottie

creakyhottie 3分前

Difference of opinion on AI

From CoPilot
Short answer: Based on the latest available preliminary Russell 2000 membership lists published by FTSE Russell on June 5, 2026, Ondas Holdings (ONDS) does not appear on the additions list.

🧭 What the data actually

jhdf51

Yes that would be a dream.

JHD

ollik78

ollik78 3分前

Monksdream

Monksdream 3分前

Lone Clone

Lone Clone 3分前

Eastport Announces Additional Positive Assay Results at the Foley Uranium Discovery

https://www.newsfilecorp.com/release/300666/Eastport-Announces-Additional-Positive-Assay-Results-at-the-Foley-Uranium-Discovery

June 09, 2026 7:30 AM EDT | Source: Eastport Critical Met

Farmboynate

Farmboynate 3分前

and their stock is the biggest POS on the market

Monksdream

Monksdream 4分前

MTEN there it goes

DeadCellShadix

DeadCellShadix 4分前

Ya I’m an idiot on the sidelines for most of these but my time will come ;-)

HenryB3

HenryB3 4分前

Personal piggy bank, eh? Why not keep the scam going, eh? Free stock, warrants, bloated bonus' and salaries. But have no fear, the buyout, merger, and uplisting are coming. When? In the year 2056. The Pump and dump is on, been telling you all that drink the kool aide don't fall for it. Typical OTC

I am done

I am done 5分前

$AMLM AI promises safer mining, but can it cut settlement risk?
https://www.globalminingreview.com/mining/08062026/ai-promises-safer-mining-but-can-it-cut-settlement-risk/

againstallodds

againstallodds 5分前

Looks like Bishop mill ceased operation

Duke Knockem

Duke Knockem 5分前

OTC stocks never run out of shares to dump with a float bigger than 100m. there will be no more seller once we hit 0.0001

Porch Honkey

Porch Honkey 5分前

What news, it hit 17 this morning, many are stuck and refuse to sell for a loss.

Lone Clone

Lone Clone 5分前

BARRANCO GOLD MINING ENGAGES RIO MINERALS TO SUPPORT 2026 EXPLORATION PLANNING AT THE KING PROPERTY

https://www.newswire.ca/news-releases/barranco-gold-mining-corp-engages-rio-minerals-ltd-to-support-2026-exploration-planning-at-the-king-property-840331169.html

News pro

tdbowieknife

tdbowieknife 5分前

The many Kepler "companies" are used to scam folks into investing in fantasies... They are liars and fraudsters. The Texatron is just another story to get folks to give them money for worthless stock. An OTC insider enrichment scheme.

Complaint:

https://drive.google.com

Newron Pharmaceuticals

Inav Db Xtrackers Short ...

Equity Bancshares

Zero Coupon Notes due 11...

Xtrackers MSCI AC Asia e...

Drozapol-profil

American Express

0.75% until 20feb2032

Interstar Mill SR062G

Bond 3875% until March 1...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。